Pregnancy Clinical Trial
Official title:
Evaluating How a Mobile App Can Improve Prenatal Care: A Randomized Controlled Trial
Verified date | October 2017 |
Source | Henry M. Jackson Foundation for the Advancement of Military Medicine |
Contact | n/a |
Is FDA regulated | No |
Health authority | |
Study type | Interventional |
Throughout the Military Health System, pregnant mothers are issued a spiral-bound guide that
provides week by week information about pregnancy, preventive health messages, appointment
information, and space to record their experiences throughout their pregnancy. When used
accordingly, the evidence-based guide is an effective tool for motivating patients to
participate in their own healthcare and achieve care goals. However, the spiral-bound paper
modality results in patients forgetting the book for appointments or losing it. By testing a
mobile application (app) from the current publication, the MHS leverages the efforts which
created the guide while increasing patient and provider use.
The multisite testing (randomized controlled trial) of a mobile application developed from
the current spiral-bound "Pregnancy and Childbirth: A Goal Oriented Guide to Prenatal Care"
created by the VA and DoD provides an innovative, cost-effective opportunity to improve
provider-patient communication and patient care.
Status | Completed |
Enrollment | 241 |
Est. completion date | December 31, 2015 |
Est. primary completion date | August 30, 2015 |
Accepts healthy volunteers | Accepts Healthy Volunteers |
Gender | Female |
Age group | 18 Years and older |
Eligibility |
Inclusion Criteria: Women (older than 18 years) who initiate obstetrics care (in the Women's Health or Family Health clinics) at the three sites. Exclusion Criteria: Exclusion criteria in this study follow the guidelines for patients who are escalated in obstetrical care, to include… 1. Cardiovascular disease 2. Cardiac abnormality 3. Diabetes Mellitus - Type I or Type II 4. Renal disorder 5. Uncontrolled hypertension 6. HIV positive 7. Hepatitis B or C positive 8. History of syphilis/RPR positive 9. Uncontrolled thyroid disease 10. History of previous bariatric surgery 11. Hematologic conditional with the exception of mild anemia 12. Cancer: current or recurrent 13. History of seizure disorder or other neurological condition 14. History of lupus or other autoimmune disorder 15. Antiphospholipid syndrome 16. History of transplant 17. History of genetics disease with known effect on pregnancy 18. Chronic pulmonary disease with the exception of well controlled 19. History of inflammatory bowel disease 20. Thromboembolic disease: current or previous 21. Recurrent pregnancy loss 22. History of isoimmunization |
Country | Name | City | State |
---|---|---|---|
n/a |
Lead Sponsor | Collaborator |
---|---|
Henry M. Jackson Foundation for the Advancement of Military Medicine |
Ledford CJW, Canzona MR, Cafferty LA, Hodge JA. Mobile application as a prenatal education and engagement tool: A randomized controlled pilot. Patient Educ Couns. 2016 Apr;99(4):578-582. doi: 10.1016/j.pec.2015.11.006. Epub 2015 Nov 10. — View Citation
Ledford CJW, Womack JJ, Rider HA, Seehusen AB, Conner SJ, Lauters RA, Hodge JA. Unexpected Effects of a System-Distributed Mobile Application in Maternity Care: A Randomized Controlled Trial. Health Educ Behav. 2017 Sep 1:1090198117732110. doi: 10.1177/10 — View Citation
Type | Measure | Description | Time frame | Safety issue |
---|---|---|---|---|
Primary | Portability across time | Question if a patient brings tool to appointments and uses it between appointments | 16-20 weeks gestation, 28 weeks gestation, 32 weeks gestation, 36 weeks gestation | |
Primary | Patient activation across time | Patient activation, defined as the knowledge, skills, and confidence to self-manage health | 8-10 weeks gestation, 32 weeks gestation | |
Primary | Prenatal Interpersonal Processes of Care across time | Patient perception of the prenatal providers communicative behavior | 16-20 weeks gestation, 28 weeks gestation, 32 weeks gestation, 36 weeks gestation |
Status | Clinical Trial | Phase | |
---|---|---|---|
Completed |
NCT03442582 -
Afluria Pregnancy Registry
|
||
Terminated |
NCT02161861 -
Improvement of IVF Fertilization Rates, by the Cyclic Tripeptide FEE - Prospective Randomized Study
|
N/A | |
Not yet recruiting |
NCT05934318 -
L-ArGinine to pRevent advErse prEgnancy Outcomes (AGREE)
|
N/A | |
Enrolling by invitation |
NCT05415371 -
Persistent Poverty Counties Pregnant Women With Medicaid
|
N/A | |
Completed |
NCT04548102 -
Effects of Fetal Movement Counting on Maternal and Fetal Outcome Among High Risk Pregnant Woman
|
N/A | |
Completed |
NCT03218956 -
Protein Requirement During Lactation
|
N/A | |
Completed |
NCT02191605 -
Computer-delivered Screening & Brief Intervention for Marijuana Use in Pregnancy
|
N/A | |
Completed |
NCT02223637 -
Meningococcal Quadrivalent CRM-197 Conjugate Vaccine Pregnancy Registry
|
||
Recruiting |
NCT06049953 -
Maternal And Infant Antipsychotic Study
|
||
Completed |
NCT02577536 -
PregSource: Crowdsourcing to Understand Pregnancy
|
||
Not yet recruiting |
NCT06336434 -
CREATE - Cabotegravir & Rilpivirine Antiretroviral Therapy in Pregnancy
|
Phase 1/Phase 2 | |
Not yet recruiting |
NCT05412238 -
Formulation and Evaluation of the Efficacy of Macro- and Micronutrient Sachets on Pregnant Mothers and Children Aged 6-60 Months
|
N/A | |
Not yet recruiting |
NCT04786587 -
Alcohol Self-reporting During Pregnancy. AUTOQUEST Study.
|
||
Not yet recruiting |
NCT05028387 -
Telemedicine Medical Abortion Service Using the "No-test" Protocol in Ukraine and Uzbekistan.
|
||
Completed |
NCT02683005 -
Study of Hepatitis C Treatment During Pregnancy
|
Phase 1 | |
Completed |
NCT02783170 -
Safety and Immunogenicity of Simultaneous Tdap and IIV in Pregnant Women
|
Phase 4 | |
Recruiting |
NCT02619188 -
Nutritional Markers in Normal and Hyperemesis Pregnancies
|
N/A | |
Recruiting |
NCT02507180 -
Safely Ruling Out Deep Vein Thrombosis in Pregnancy With the LEFt Clinical Decision Rule and D-Dimer
|
||
Recruiting |
NCT02564250 -
Maternal Metabolism and Pregnancy Outcomes in Obese Pregnant Women
|
N/A | |
Completed |
NCT02528136 -
The Clinical Carbetocin Myocardium Trial
|
Phase 4 |